Predominantly Classic CNV Treated with Visudyne Therapy TAP

Скачать презентацию Predominantly Classic CNV Treated with Visudyne Therapy TAP Скачать презентацию Predominantly Classic CNV Treated with Visudyne Therapy TAP

case_09_treated_predom_classic_cnv_(tap).ppt

  • Размер: 952.0 Кб
  • Автор:
  • Количество слайдов: 27

Описание презентации Predominantly Classic CNV Treated with Visudyne Therapy TAP по слайдам

Predominantly Classic CNV Treated with Visudyne Therapy TAP Investigation Case Study Predominantly Classic CNV Treated with Visudyne Therapy TAP Investigation Case Study

Case Notes 67 -year-old woman – Presented with recent vision loss in her rightCase Notes 67 -year-old woman – Presented with recent vision loss in her right eye Visual acuity – Right eye 0. 16 (20/126) – Left eye 0. 8 (20/25) Patient was enrolled in the TAP Investigation

Baseline Color Fundus Photograph Baseline Color Fundus Photograph

Baseline Early-phase Fluorescein Angiogram Baseline Early-phase Fluorescein Angiogram

Baseline Mid-phase Fluorescein Angiogram Baseline Mid-phase Fluorescein Angiogram

Baseline Late-phase Fluorescein Angiogram Baseline Late-phase Fluorescein Angiogram

3 -month Follow-up Color Fundus Photograph VA right eye:  0. 1 (20/200) 3 -month Follow-up Color Fundus Photograph VA right eye: 0. 1 (20/200)

3 -month Follow-up Early-phase Fluorescein Angiogram 3 -month Follow-up Early-phase Fluorescein Angiogram

3 -month Follow-up Mid-phase Fluorescein Angiogram 3 -month Follow-up Mid-phase Fluorescein Angiogram

3 -month Follow-up Late-phase Fluorescein Angiogram 3 -month Follow-up Late-phase Fluorescein Angiogram

6 -month Follow-up Color Fundus Photograph VA right eye:  0. 16 (20/126) 6 -month Follow-up Color Fundus Photograph VA right eye: 0. 16 (20/126)

6 -month Follow-up Early-phase Fluorescein Angiogram 6 -month Follow-up Early-phase Fluorescein Angiogram

6 -month Follow-up Mid-phase Fluorescein Angiogram 6 -month Follow-up Mid-phase Fluorescein Angiogram

6 -month Follow-up Late-phase Fluorescein Angiogram 6 -month Follow-up Late-phase Fluorescein Angiogram

9 -month Follow-up Color Fundus Photograph VA right eye:  0. 2 (20/100) 9 -month Follow-up Color Fundus Photograph VA right eye: 0. 2 (20/100)

9 -month Follow-up Early-phase Fluorescein Angiogram 9 -month Follow-up Early-phase Fluorescein Angiogram

9 -month Follow-up Mid-phase Fluorescein Angiogram 9 -month Follow-up Mid-phase Fluorescein Angiogram

9 -month Follow-up Late-phase Fluorescein Angiogram 9 -month Follow-up Late-phase Fluorescein Angiogram

12 -month Follow-up Color Fundus Photograph VA right eye:  0. 2 (20/100) 12 -month Follow-up Color Fundus Photograph VA right eye: 0. 2 (20/100)

12 -month Follow-up Early-phase Fluorescein Angiogram 12 -month Follow-up Early-phase Fluorescein Angiogram

12 -month Follow-up Mid-phase Fluorescein Angiogram 12 -month Follow-up Mid-phase Fluorescein Angiogram

12 -month Follow-up Late-phase Fluorescein Angiogram 12 -month Follow-up Late-phase Fluorescein Angiogram

15 -month Follow-up Patient was retreated with Visudyne therapy (no photographs shown) Schedule for15 -month Follow-up Patient was retreated with Visudyne therapy (no photographs shown) Schedule for follow-up in 3 months

18 -month Follow-up Color Fundus Photograph VA right eye:  0. 1 (20/200) 18 -month Follow-up Color Fundus Photograph VA right eye: 0. 1 (20/200)

18 -month Follow-up Early-phase Fluorescein Angiogram 18 -month Follow-up Early-phase Fluorescein Angiogram

18 -month Follow-up Mid-phase Fluorescein Angiogram 18 -month Follow-up Mid-phase Fluorescein Angiogram

18 -month Follow-up Late-phase Fluorescein Angiogram 18 -month Follow-up Late-phase Fluorescein Angiogram